CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 622 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04628039
NCT04628039N/ACompleted

Chronic Lung Disease and COVID-19: Understanding Severity, Recovery and Rehabilitation Needs (LAUREL Study)

VA Office of Research and Development·observational·Posted Nov 13, 2020·Updated Jan 22, 2026

In Brief

An observational study for COVID-19 and Chronic Lung Diseases. Completed, enrolled 622 participants across 2 sites.

Detailed Summary

This is study is comprised of three approaches. First, the investigators will conduct a retrospective cohort study to determine factors associated with COVID-19 severity and complications and understand COVID-19 outcomes, including all-cause mortality, post-discharge events, and impacts of rehabilitation services (third aim). The second aim is a mixed-method study and follows COVID-19 patients with repeated surveys to determine patient-reported functional outcomes, health recovery, and rehabilitation needs after COVID-19. The investigators will recruit patients and their informal caregivers for interviews to assess their function and rehabilitation needs.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
202120222023202420252026
First PostedNov 13, 2020
Enrollment StartMay 27, 2021
Primary CompletionNov 12, 2025
Study CompletionDec 31, 2025
TodayJul 2, 2026
Enrollment to primary: 4.5 yearsPosted 5.6 years ago